Literature DB >> 35763122

Effect of Repetitive Transcranial Magnetic Stimulation on Post-stroke Dysphagia: A Meta-analysis of Stimulation Frequency, Stimulation Site, and Timing of Outcome Measurement.

Ming-Yen Hsiao1,2, Yoo Jin Choo3, I-Chun Liu2, Mathieu Boudier-Revéret4, Min Cheol Chang5.   

Abstract

Dysphagia is one of the most frequent sequelae of stroke. It can result in various complications such as malnutrition, dehydration, aspiration pneumonia, and poor rehabilitation outcomes. Repetitive transcranial magnetic stimulation (rTMS) has been reported to improve dysphagia after a stroke; however, effective treatment protocols have not been established yet. We evaluated the effect of the following rTMS parameters on post-stroke dysphagia: stimulation frequency [high frequency (≥ 3 Hz) or low frequency (1 Hz)] and stimulation site (ipsilesional or contralesional mylohyoid cortex). Outcomes were measured immediately, at 3 weeks, and at 4 weeks after the rTMS session. The PubMed, SCOPUS, Embase, and Cochrane Library databases were systematically searched for relevant studies published between January 01, 1980, and December 13, 2021. Randomized controlled trials on the effects of rTMS on post-stroke dysphagia were included. Six studies were finally included in the analysis. The selected studies included 158 patients (rTMS group: 81 patients; sham group: 77 patients). Regarding the effect of high-frequency rTMS on the ipsilesional cortex, the standardized swallowing assessment (SSA) scores showed significant improvement after rTMS sessions immediately and at 4 weeks [immediate: P = 0.02, standard mean difference (SMD) =  - 0.61, 95% confidence interval (CI) =  - 1.14 to - 0.08; 4 weeks: P = 0.006, SMD =  - 0.74, 95% CI =  - 1.27 to - 0.21]; however, there was no significant reduction in the Penetration-Aspiration Scale (PAS) scores between the rTMS and sham groups (immediate: P = 0.43, SMD = 0.25, 95% CI =  - 0.36, 0.86; 3 weeks: P = 0.39, SMD = 0.37, 95% CI =  - 0.47 to 1.22). After low-frequency rTMS on the ipsilesional cortex, a significantly greater improvement in the SSA scores was found in the rTMS group than in the sham group, both immediately and at 4 weeks after rTMS sessions (immediate: P = 0.03, SMD =  - 0.59, 95% CI =  - 1.12 to - 0.06; 4 weeks: P = 0.001, SMD =  - 0.92, 95% CI =  - 1.48 to - 0.37). In addition, immediately after the rTMS sessions, the PAS scores were significantly reduced in the rTMS group than in the sham group (P = 0.047, SMD =  - 0.60, 95% CI =  - 1.19 to - 0.01). However, at 4 weeks after rTMS sessions, there was no significant reduction in the PAS scores in the rTMS group compared to the sham group (P = 0.48, SMD =  - 0.19, 95% CI =  - 0.71 to 0.33). Both high-frequency rTMS of the ipsilesional cortex and low-frequency rTMS of the contralesional cortex improved some measurements of the swallowing function in stroke patients immediately and at 4 weeks after treatment.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Dysphagia; Meta-analysis; Repetitive transcranial magnetic stimulation; Stroke

Year:  2022        PMID: 35763122     DOI: 10.1007/s00455-022-10483-9

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  43 in total

1.  Neuronavigated high-frequency repetitive transcranial magnetic stimulation for chronic post-stroke dysphagia: A randomized controlled study.

Authors:  Ivy K Y Cheng; Karen M K Chan; Chun-Sing Wong; Leonard S W Li; Karen M Y Chiu; Raymond T F Cheung; Edwin M L Yiu
Journal:  J Rehabil Med       Date:  2017-06-28       Impact factor: 2.912

2.  Social and psychological burden of dysphagia: its impact on diagnosis and treatment.

Authors:  Olle Ekberg; Shaheen Hamdy; Virginie Woisard; Anita Wuttge-Hannig; Primitivo Ortega
Journal:  Dysphagia       Date:  2002       Impact factor: 3.438

Review 3.  Dysphagia after stroke: incidence, diagnosis, and pulmonary complications.

Authors:  Rosemary Martino; Norine Foley; Sanjit Bhogal; Nicholas Diamant; Mark Speechley; Robert Teasell
Journal:  Stroke       Date:  2005-11-03       Impact factor: 7.914

4.  Repetitive transcranial magnetic stimulation for rehabilitation of poststroke dysphagia: A randomized, double-blind clinical trial.

Authors:  Juan Du; Fang Yang; Ling Liu; Jingze Hu; Biyang Cai; Wenhua Liu; Gelin Xu; Xinfeng Liu
Journal:  Clin Neurophysiol       Date:  2015-12-11       Impact factor: 3.708

5.  Therapeutic role of rTMS on recovery of dysphagia in patients with lateral medullary syndrome and brainstem infarction.

Authors:  Eman M Khedr; Noha Abo-Elfetoh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-10-14       Impact factor: 10.154

6.  Dysphagia in patients with isolated pontine infarction.

Authors:  Min Cheol Chang; Sang Gyu Kwak; Min Ho Chun
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135

7.  Comparison of three different types of exercises for selective contractions of supra- and infrahyoid muscles.

Authors:  Min Cheol Chang; Sungwon Park; Joo Young Cho; Byung Joo Lee; Jong-Moon Hwang; KwanMyung Kim; Donghwi Park
Journal:  Sci Rep       Date:  2021-03-30       Impact factor: 4.379

Review 8.  Effects of transcranial magnetic stimulation in modulating cortical excitability in patients with stroke: a systematic review and meta-analysis.

Authors:  Zhongfei Bai; Jiaqi Zhang; Kenneth N K Fong
Journal:  J Neuroeng Rehabil       Date:  2022-02-22       Impact factor: 4.262

Review 9.  Neurostimulation in People with Oropharyngeal Dysphagia: A Systematic Review and Meta-Analysis of Randomised Controlled Trials-Part II: Brain Neurostimulation.

Authors:  Renée Speyer; Anna-Liisa Sutt; Liza Bergström; Shaheen Hamdy; Timothy Pommée; Mathieu Balaguer; Anett Kaale; Reinie Cordier
Journal:  J Clin Med       Date:  2022-02-14       Impact factor: 4.241

10.  Swallowing therapy for dysphagia in acute and subacute stroke.

Authors:  Philip M Bath; Han Sean Lee; Lisa F Everton
Journal:  Cochrane Database Syst Rev       Date:  2018-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.